GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma

por Li, Yuan, Fan, Yibo, Xu, Jinbang, Huo, Longfei, Scott, Ailing W., Jin, Jiankang, Yang, Boxuan, Shao, Shan, Ma, Lang, Wang, Ying, Yao, Xiaodan, Pool Pizzi, Melissa, Sewastjanow Da Silva, Matheus, Zhang, Guoliang, Zhuo, Lijuan, Cho, Eun Jeong, Dalby, Kevin N., Shanbhag, Namita D., Wang, Zhenning, Li, Wenliang, Song, Shumei, Ajani, Jaffer A.
Publicado 2022